In Brief: Bristol-Myers Squibb
This article was originally published in The Gray Sheet
Executive Summary
Bristol-Myers Squibb: Zimmer subsidiary acquires craniofacial implant line from Anspach Fixation Devices, Inc. The line, which will be marketed under the Zimmer name, consists of "micro-sized bone titanium plates and bone screws for craniofacial/maxillofacial and neurological bone reconstruction," Zimmer says. The product line will complement Zimmer's ECT Internal Fracture Fixation, the firm says, and "will increase the number of indications that trauma surgeons can address with Zimmer systems." Zimmer also plans to apply the technology to other subspecialties such as hand surgery and small-bone fixation...